BlackRock, Inc. Updates Ownership in ANI Pharmaceuticals Inc.

BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting its ownership of 2,517,424 shares of ANI Pharmaceuticals Inc., representing 11.3% of the company's common stock. The filing indicates that BlackRock has sole voting power over 2,482,925 shares and sole dispositive power over all 2,517,424 shares. The filing also notes that various persons have the right to receive dividends or proceeds from the sale of the shares, but no single person's interest exceeds 5% of the total outstanding shares. The amendment was filed on October 17, 2025, and certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose of influencing control of the issuer.